In 2026, the spotlight will be on a handful of therapeutic strategies that could change cancer care for patients by offering ...

Lantern showcases two commercially ready, machine learning platforms that have the potential to accelerate drug discovery from months to days and dramatically reduce costs. predictBBB.ai and LBx-AI, ...

BOSTON, MA, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- Oncoheroes Biosciences, a biotech company exclusively ...

Many breast cancer drugs block estrogen receptors inside cancer cells. Blocking the receptors early in disease progression staves off metastasis. But most patients with advanced disease eventually ...

A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a ...

Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told BioSpace, with both rare and chronic diseases headlining investor and R&D ...

CAMBRIDGE, England--(BUSINESS WIRE)--Crescendo Biologics Ltd (Crescendo), the developer of novel, targeted, T cell enhancing therapeutics, and Cancer Research UK, the world’s largest independent ...

Advances in cancer research have led to an increasing number and variety of cancer therapies in the development pipeline, but there are concerns that traditional processes for drug development, ...

Decoding the complex communication system of the deadliest brain cancer has revealed that an already approved HIV drug could ...